Description
/* Reset & Base */
* {
box-sizing: border-box;
margin: 0;
padding: 0;
}
body {
font-family: ‘Inter’, -apple-system, BlinkMacSystemFont, ‘Segoe UI’, Roboto, Helvetica, Arial, sans-serif;
background: #fff;
color: #1e1e1e;
line-height: 1.6;
}
/* Utilities */
.sm-container {
max-width: 1300px;
margin: 0 auto;
padding: 20px 32px 60px;
width: 100%;
}
.sm-flex {
display: flex;
flex-wrap: wrap;
}
.sm-grid-2 {
display: grid;
grid-template-columns: 1fr 1fr;
gap: 40px;
}
.sm-grid-3 {
display: grid;
grid-template-columns: repeat(3, 1fr);
gap: 24px;
}
.sm-grid-4 {
display: grid;
grid-template-columns: repeat(4, 1fr);
gap: 20px;
}
/* Tabs */
.sm-tab-input {
display: none;
}
.sm-panel {
display: none;
}
#sm-tab-product:checked~.sm-tab-nav label[for=”sm-tab-product”],
#sm-tab-disclaimer:checked~.sm-tab-nav label[for=”sm-tab-disclaimer”] {
background: #F27444;
color: #fff;
border-color: #F27444;
box-shadow: 0 8px 20px rgba(242, 116, 68, 0.25);
}
#sm-tab-product:checked~.sm-product-panel {
display: block;
}
#sm-tab-disclaimer:checked~.sm-disclaimer-panel {
display: block;
}
/* FAQ */
.sm-faq summary::-webkit-details-marker {
display: none;
}
.sm-faq[open] .sm-plus {
transform: rotate(45deg);
}
/* Chips */
.sm-chip {
display: inline-block;
padding: 8px 16px;
border-radius: 999px;
background: #fff4ef;
border: 1px solid #ffd9cb;
color: #F27444;
font-weight: 600;
font-size: 0.9rem;
margin: 4px 6px 4px 0;
letter-spacing: 0.02em;
}
/* Cards & Hover */
.sm-card {
background: #fff;
border: 1px solid #f0e8e4;
border-radius: 28px;
padding: 28px;
transition: all 0.2s ease-in-out;
}
.sm-card:hover {
transform: translateY(-4px);
box-shadow: 0 20px 40px -12px rgba(0, 0, 0, 0.08);
border-color: #F27444;
}
.sm-card-glow {
background: linear-gradient(135deg, #fff 0%, #fff8f5 100%);
border: 1px solid #ffe1d6;
}
/* Specs Zebra */
.sm-spec-grid {
display: grid;
grid-template-columns: 1fr 1fr;
}
.sm-spec-item {
padding: 16px 24px;
border-bottom: 1px solid #f0e8e4;
background: #fff;
}
.sm-spec-item:nth-child(odd) {
background: #fcfaf9;
}
/* Responsive */
@media(max-width:768px) {
.sm-container {
padding: 20px 16px 40px;
}
.sm-grid-2,
.sm-grid-3,
.sm-grid-4 {
grid-template-columns: 1fr !important;
gap: 20px;
}
.sm-spec-grid {
grid-template-columns: 1fr;
}
.sm-tab {
width: 100% !important;
text-align: center !important;
}
.sm-hero-title {
font-size: 32px !important;
}
h2 {
font-size: 24px !important;
}
}
/* Misc */
.sm-tab {
font-size: 1rem;
padding: 12px 32px;
border-radius: 999px;
background: #fff;
border: 1px solid #e0d6d0;
color: #1e1e1e;
cursor: pointer;
font-weight: 600;
transition: all 0.2s;
user-select: none;
}
.sm-tab:hover {
background: #fff4ef;
border-color: #F27444;
}
.sm-hero-bg {
background: radial-gradient(ellipse at 70% 20%, rgba(242, 116, 68, 0.04) 0%, rgba(255, 255, 255, 0) 70%);
}
/* Reference list item hover */
.ref-item {
padding: 16px 20px;
background: #fff;
border-radius: 16px;
border: 1px solid #f0e8e4;
transition: all 0.2s ease-in-out;
}
.ref-item:hover {
border-color: #F27444;
box-shadow: 0 4px 12px rgba(242, 116, 68, 0.08);
}
.ref-item a {
color: #F27444;
font-weight: 700;
text-decoration: none;
}
.ref-item a:hover {
text-decoration: underline;
}
SaiyanMed Research Grade
IGF-1 LR3
Long [Arg3] IGF-1 — 83-aa IGF-1 analog and IGF-1R agonist with reduced IGFBP binding · research grade
Research-grade IGF-1 LR3 (Long [Arg3] Insulin-like Growth Factor-1) is an 83-amino-acid synthetic analog of human IGF-1, supplied for laboratory study of IGF-1-receptor (IGF-1R) signalling, cell proliferation, and protein/DNA-synthesis research models. Two structural modifications — a 13-amino-acid N-terminal extension and an Arg3 substitution — sharply reduce binding to IGF-binding proteins (IGFBPs), extending half-life and potency relative to native IGF-1. Each vial is lyophilized, ≥98% HPLC pure, MS-confirmed, and supported by publicly verifiable third-party COAs published in our Trust Center. For research use only — not for human or veterinary use.
≥98% HPLC
MS Confirmed
Third-Party COA
Lyophilized
Global Warehouse Fulfillment
IGF-1 Receptor Agonist
IGF-1R · PI3K/Akt · MAPK/ERK
Designed for research models studying IGF-1-receptor signalling, cell proliferation, differentiation, and IGFBP-independent IGF-1 pathway research.
83 AA
CAS 946870-92-4
RUO
Research Context
Mechanistic Study Tool
IGF-1 LR3 is positioned for mechanistic research into IGF-1-receptor signalling and IGFBP-independent pathway modulation rather than human therapeutic or personal-use applications.
IGF-1R Agonism
PI3K/Akt
MAPK/ERK
What is IGF-1 LR3?
IGF-1 LR3 (Long [Arg3] IGF-1) is a synthetic, lengthened analog of human insulin-like growth factor 1 (IGF-1). It differs from native IGF-1 (70 amino acids) by two modifications: a 13-amino-acid N-terminal extension (the “Long”) and the substitution of arginine for glutamic acid at position 3 (Glu3→Arg3, the “R3”), for a total of 83 amino acids.
Because position 3 lies within the IGFBP-binding domain, the charge reversal disrupts IGF-binding-protein interaction — reducing IGFBP affinity roughly 100-fold while preserving full agonist activity at the type-1 IGF receptor (IGF-1R). In research models this translates to greater metabolic stability, a longer half-life (~20–30 h), and higher potency than native IGF-1.
As an IGF-1R agonist, IGF-1 LR3 activates the PI3K/Akt and MAPK/ERK pathways, and is used as a research tool to study cell proliferation, differentiation, protein and DNA synthesis, and IGFBP-independent IGF-1 signalling.
🧪 Research Applications
①
IGF-1R Signalling
IGF-1-receptor activation and PI3K/Akt, MAPK/ERK pathway research models.
②
Cell Proliferation / Differentiation
Cell-proliferation and differentiation research models.
③
Protein / DNA Synthesis
Protein- and DNA-synthesis research (e.g. cultured myoblast models).
④
IGFBP-Independent Signalling
IGF-1 signalling research with reduced IGF-binding-protein interference.
⑤
Comparative vs Native IGF-1
Potency and half-life comparison vs native IGF-1 research models.
⑥
Cell-Survival / Anti-Apoptosis
Anti-apoptotic and cell-survival research models.
📊 Quick Specs
Form: Lyophilized powder (white to off-white)
Purity: ≥98% by HPLC
Identity: MS molecular-weight confirmed
CAS Number: 946870-92-4
Also Known As: Long R3-IGF-1, LR3-IGF-1, Long [Arg3] IGF-1
Length: 83 amino acids (native IGF-1 = 70 aa)
Modifications: 13-aa N-terminal extension (“Long”) + Arg3 substitution (Glu3→Arg3, “R3”)
Molecular Formula: C400H625N111O115S9
Molecular Weight: ~9111 Da (native IGF-1 ~7649 Da)
Receptor: IGF-1 receptor (IGF-1R) agonist
Key Property: ~100-fold reduced IGFBP binding; ~3× potency; half-life ~20–30 h
Signalling: PI3K/Akt and MAPK/ERK pathways
COA: Third-party lab tested — publicly verifiable
Manufacture: Lyophilized & QC-released in-house
Storage: −20°C sealed | 2–8°C reconstituted
Shelf Life: 24 months unopened (lyophilized)
VERIFIED
Certificate of Analysis
Independent Third-Party Validation
Transparency is central to our quality assurance. Batches undergo orthogonal analytical testing by an independent third-party laboratory. The resulting Certificate of Analysis (COA) details specific HPLC chromatograms and MS spectra for that lot. End‑users can cross‑validate the document online via the SaiyanMed Trust Center using the unique batch identifier printed on the vial label.
Batch‑specific documentation ensures full traceability for your laboratory records. Always confirm the batch reference matches the product vial before use.
📦 Storage & Handling
🧊 Storage
Lyophilized vials: store at −20°C, sealed, protected from light and moisture. After reconstitution: store at 2–8°C and use within 2–4 weeks (study-defined stability window). Avoid repeated freeze-thaw cycles. Do not use if the reconstituted solution is cloudy or contains visible particles.
💧 Reconstitution
Reconstitute with sterile bacteriostatic water or a dilute acid solution (e.g. 10 mM HCl) per your protocol; add slowly down the inside wall of the vial and swirl gently — do not shake. Prepare working dilutions per your laboratory protocol.
🚚 Fulfillment & Transit Notice
Global logistics: Orders ship from the nearest available warehouse. US-based warehouse fulfillment is available for domestic US orders; international orders ship from our Asian logistics hub with an estimated 7–14 day global delivery window.
Temperature in transit: Lyophilized peptides are stable at ambient temperature for the normal transit window. Brief temperature excursions during shipping do not compromise the lyophilized product. Refrigerate on arrival per the storage guidance above.
Customs handling: Cross-border research-chemical shipments may occasionally be subject to customs inspection or delay. This is normal for international scientific shipping and does not indicate a problem with the product.
Delays or holds: If a shipment is delayed beyond the estimated window or held in customs, contact us with your order reference. We will assist with tracking and, where applicable, arrange a reshipment in line with our shipping policy.
Damaged or incorrect items: Inspect on arrival; contact us within the period stated in our shipping policy, with photos, for resolution.
⚠️
Research Use Only
This material is supplied only for qualified laboratory research and is not intended for human or veterinary use.
Research Use Only
Not for Human Consumption
SaiyanMed products are strictly for in vitro and in vivo laboratory research. They are not intended for diagnostic, therapeutic, medical, disease-prevention, consumer health, or personal use.
All SaiyanMed products are supplied for laboratory, scientific, and research use only. They are not for human consumption, medical treatment, diagnosis, disease prevention, or veterinary use.
✅ Buyer Confirmation
✓ You are a qualified researcher or acting under the supervision of one.
✓ Products will only be used for legitimate research purposes.
✓ Products are not evaluated by the FDA or any regulatory authority for human use.
✓ You assume responsibility for legal compliance, proper handling, storage, and disposal.
No Warranty: Products are sold “as is,” with no express or implied warranties regarding efficacy, safety, or suitability. Results in research may vary. SaiyanMed is not responsible for outcomes, interpretations, or conclusions drawn from any studies conducted using these products.
🛡️ General Safety & Handling
🚫 Not for Human Use
These compounds are for research only. Any off-label, personal, or clinical use is outside the intended scope.
🥽 PPE Required
Always use appropriate personal protective equipment, including gloves, lab coat, and eye protection.
🌡 Storage Compliance
Follow product-specific storage conditions to maintain identity, purity, and biological activity.
🗑 Proper Disposal
Dispose of all materials according to institutional biosafety, chemical waste, and hazardous material protocols.
🧾 Verify Quality
Verify batch identity, MS confirmation, HPLC purity, and COA status before research use.
⚖ Legal Compliance
Researchers are responsible for lawful purchase, possession, storage, and use in their jurisdiction.
💬 Frequently Asked Questions
What is IGF-1 LR3?+
IGF-1 LR3 (Long [Arg3] IGF-1) is an 83-amino-acid synthetic analog of human IGF-1 and an IGF-1R agonist, supplied strictly as a research reference compound for cell-proliferation and IGF-1-signalling research models. Not for human or veterinary use.
What do “Long” and “R3” mean?+
“Long” refers to a 13-amino-acid N-terminal extension; “R3” refers to an arginine substitution at position 3 (Glu3→Arg3). Together they reduce IGF-binding-protein interaction.
How does it differ from native IGF-1?+
It has ~100-fold reduced IGFBP binding, roughly threefold greater potency, and a longer half-life (~20–30 h) than native IGF-1 in research models.
How is purity verified?+
Published lots are tested to ≥98% by HPLC with identity confirmed by mass spectrometry; a third-party COA is published and independently verifiable.
Is this intended for human use?+
No. This material is strictly for laboratory research use only and is not for human or veterinary use.
📚 References
PubChem:
IGF-1 LR3 / Long R3-IGF-1 (CID 16137828) – compound summary, molecular formula, and properties.
View at PubChem ↗
PubMed (National Library of Medicine):
Search results for “Long R3 IGF-1” – comprehensive index of published research.
Search PubMed ↗
Francis GL, et al. (1992):
Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I … Long [Arg3] IGF-I.
J Mol Endocrinol 9(3):213-223. (L6 myoblast protein/DNA synthesis).
View at PubMed ↗
Sara VR, Hall K (1990):
Insulin-like growth factors and their binding proteins.
Physiol Rev 70(3):591-614. (IGFBP interactions and receptor binding).
View at PubMed ↗
Jones JI, Clemmons DR (1995):
Insulin-like growth factors and their binding proteins: biological actions.
Endocr Rev 16(1):3-34. (IGF-1R signalling and IGFBP modulation).
View at PubMed ↗





Reviews
There are no reviews yet.